KAINOS Laboratories, Inc. announces an Equity Buyback for 150,000 shares, for ¥158.1 million.
November 25, 2021 at 01:50 am EST
Share
KAINOS Laboratories, Inc. (JASDAQ:4556) announces a share repurchase program. Under the program, the company will repurchase up to 150,000 shares, representing 3.43% of its issued share capital for ¥158.1 million. The shares will be repurchased at a price of ¥1,054 per share. The purpose of the program is execution of agile capital policies in response to changes in the business environment. The program is valid till November 26, 2021. As of September 30, 2021, the company had 4,369,204 shares issued (excluding treasury stock) and 189,656 shares in treasury.
KAINOS Laboratories, Inc. is pricipally engaged in researching, developing, manufacturing and selling clinical diagnostic reagents, including biochemical diagnostic reagents such as renal function related reagents and automatic biochemical analytical reagents, immune serological test reagents such as transfusion-related reagents, allergy-related reagents, cancer marker related reagents, and other reagents.
KAINOS LABORATORIES, INC. 
